Publications by authors named "S Escaich"

Claim this Profile
N
Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model.
Carole Fournier, Marion Mercey-Ressejac, Valentin Derangère, Amal Al Kadi, David Rageot, Séverine Escaich

EBioMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis.
Rodrick Montjean, Sonia Escaich, Raffaello Paolini, Claude Carelli, Sébastien Pirson

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel HldE-K inhibitors leading to attenuated Gram negative bacterial virulence.
Nicolas Desroy, Alexis Denis, Chrystelle Oliveira, Dmytro Atamanyuk, Sophia Briet, Sonia Escaich

J Med Chem· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.
Vincent Gerusz, Alexis Denis, Fabien Faivre, Yannick Bonvin, Mayalen Oxoby, Sonia Escaich

J Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.
S Escaich, L Prouvensier, M Saccomani, L Durant, M Oxoby

Antimicrob Agents Chemother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis